Chunping Qiu

1.0k total citations
31 papers, 741 citations indexed

About

Chunping Qiu is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Chunping Qiu has authored 31 papers receiving a total of 741 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 14 papers in Cancer Research and 8 papers in Surgery. Recurrent topics in Chunping Qiu's work include Cancer-related molecular mechanisms research (8 papers), RNA modifications and cancer (7 papers) and Cancer, Lipids, and Metabolism (6 papers). Chunping Qiu is often cited by papers focused on Cancer-related molecular mechanisms research (8 papers), RNA modifications and cancer (7 papers) and Cancer, Lipids, and Metabolism (6 papers). Chunping Qiu collaborates with scholars based in China, United States and Canada. Chunping Qiu's co-authors include Jie Jiang, Beihua Kong, Samina Dongol, Zhiming Liu, Chenggong Sun, Chengjuan Jin, Beihua Kong, Qingtao Lv, Zhaojian Liu and Xingsheng Yang and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and International Journal of Cancer.

In The Last Decade

Chunping Qiu

31 papers receiving 728 citations

Peers

Chunping Qiu

IMMUN

ONCOL

Núria Eritja Spain

Zhihong Ai China

Chunliang Shang China

Kathryn N. Phoenix United States

Yuhuan Qiao China

Cristian P. Moiola Spain

Giuseppina D’Andrilli Italy

Rehana Qureshi United States

Andrzej Wincewicz Poland

J A Truglia United States

Núria Eritja Spain

Chunping Qiu

449 ×1.0

202 ×0.7

94 ×0.7

IMMUN

95 ×0.8

191 ×1.6

ONCOL

Citations per year, relative to Chunping Qiu Chunping Qiu (= 1×) peers Núria Eritja

Countries citing papers authored by Chunping Qiu

Since Specialization

Citations

This map shows the geographic impact of Chunping Qiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chunping Qiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chunping Qiu more than expected).

Fields of papers citing papers by Chunping Qiu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chunping Qiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chunping Qiu. The network helps show where Chunping Qiu may publish in the future.

Co-authorship network of co-authors of Chunping Qiu

This figure shows the co-authorship network connecting the top 25 collaborators of Chunping Qiu. A scholar is included among the top collaborators of Chunping Qiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chunping Qiu. Chunping Qiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhou, Qing, Wenzhi Li, Yao Liu, et al.. (2023). LncRNA HOXB-AS3 binding to PTBP1 protein regulates lipid metabolism by targeting SREBP1 in endometrioid carcinoma. Life Sciences. 320. 121512–121512. 7 indexed citations

Wei, Lina, Xiaohong Ma, Yixin Hou, et al.. (2023). Verteporfin reverses progestin resistance through YAP/TAZ-PI3K-Akt pathway in endometrial carcinoma. Cell Death Discovery. 9(1). 30–30. 18 indexed citations

Guo, Wenxiu, et al.. (2023). Progress of immunotherapies in gestational trophoblastic neoplasms. Journal of Cancer Research and Clinical Oncology. 149(16). 15275–15285. 3 indexed citations

Li, Fangfang, Chen Zhao, Zixiang Wang, et al.. (2022). MEX3A promotes the malignant progression of ovarian cancer by regulating intron retention in TIMELESS. Cell Death and Disease. 13(6). 553–553. 19 indexed citations

Ma, Xiaohong, Min Xia, Lina Wei, et al.. (2022). ABX-1431 inhibits the development of endometrial adenocarcinoma and reverses progesterone resistance by targeting MGLL. Cell Death and Disease. 13(12). 1067–1067. 8 indexed citations

Qiu, Chunping, Xun Zhang, Shu Yao, et al.. (2022). HJURP Promotes Malignant Progression and Mediates Sensitivity to Cisplatin and WEE1-inhibitor in Serous Ovarian Cancer. International Journal of Biological Sciences. 18(3). 1188–1210. 19 indexed citations

Ma, Xiaohong, Tianyi Zhao, Hong Yan, et al.. (2021). Fatostatin reverses progesterone resistance by inhibiting the SREBP1-NF-κB pathway in endometrial carcinoma. Cell Death and Disease. 12(6). 544–544. 42 indexed citations

Ding, Fei, Chunping Qiu, Wenzhi Li, et al.. (2021). CNR1 may reverse progesterone-resistance of endometrial cancer through the ERK pathway. Biochemical and Biophysical Research Communications. 548. 148–154. 9 indexed citations

Zhao, Chen, Yingwei Li, Chunping Qiu, et al.. (2021). Splicing Factor DDX23, Transcriptionally Activated by E2F1, Promotes Ovarian Cancer Progression by Regulating FOXM1. Frontiers in Oncology. 11. 749144–749144. 10 indexed citations

10.

Qiu, Chunping, et al.. (2021). MiR-501 promotes tumor proliferation and metastasis by targeting HOXD10 in endometrial cancer. Cellular & Molecular Biology Letters. 26(1). 20–20. 22 indexed citations

11.

Zhang, Yuanli, et al.. (2020). The diagnosis and treatment of adrenocortical carcinoma in pregnancy: a case report. BMC Pregnancy and Childbirth. 20(1). 50–50. 5 indexed citations

12.

Li, Wenzhi, Shufen Wang, Chunping Qiu, et al.. (2019). Comprehensive bioinformatics analysis of acquired progesterone resistance in endometrial cancer cell line. Journal of Translational Medicine. 17(1). 58–58. 33 indexed citations

13.

Sun, Xiaomei, Samina Dongol, Chunping Qiu, et al.. (2018). miR-652 Promotes Tumor Proliferation and Metastasis by Targeting RORA in Endometrial Cancer. Molecular Cancer Research. 16(12). 1927–1939. 66 indexed citations

14.

Xu, Ying, Chengjuan Jin, Chunping Qiu, et al.. (2018). SUSD2 promotes cancer metastasis and confers cisplatin resistance in high grade serous ovarian cancer. Experimental Cell Research. 363(2). 160–170. 30 indexed citations

15.

Liu, Zhiming, Sisi Chen, Chunping Qiu, et al.. (2018). Fractalkine/CX3CR1 Contributes to Endometriosis-Induced Neuropathic Pain and Mechanical Hypersensitivity in Rats. Frontiers in Cellular Neuroscience. 12. 495–495. 30 indexed citations

16.

Qiu, Chunping, Nan Lü, Xiao Wang, et al.. (2017). Gene expression profiles of ovarian low-grade serous carcinoma resemble those of fallopian tube epithelium. Gynecologic Oncology. 147(3). 634–641. 16 indexed citations

17.

Li, Yingwei, Haiyang Guo, Chengjuan Jin, et al.. (2017). Spliceosome-associated factor CTNNBL1 promotes proliferation and invasion in ovarian cancer. Experimental Cell Research. 357(1). 124–134. 22 indexed citations

18.

Zhang, Yifang, Lili Zhang, Hengzi Sun, et al.. (2016). Forkhead transcription factor 1 inhibits endometrial cancer cell proliferation via sterol regulatory element-binding protein 1. Oncology Letters. 13(2). 731–737. 15 indexed citations

19.

Sun, Hengzi, Yifang Zhang, Xiaoxia Che, et al.. (2015). Biglycan enhances the ability of migration and invasion in endometrial cancer. Archives of Gynecology and Obstetrics. 293(2). 429–438. 42 indexed citations

20.

Li, Lin, Xiaoxia Zheng, Chunping Qiu, et al.. (2014). SIRT1 promotes endometrial tumor growth by targeting SREBP1 and lipogenesis. Oncology Reports. 32(6). 2831–2835. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact